Certified by Founder Lodge
TRexBio
United States - South San Francisco, California
START UP
1 Disclosed Funding Rounds $84,000,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
TRexBio is a discovery stage biotechnology company leveraging cutting edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therap
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 14 ,2024 | Series B | $84,000,000 |
Johnson & Johnson
Polaris Partners
SV Health Investors
Pfizer
Agent Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
